Natural quorum sensing inhibitors effectively downregulate gene expression of Pseudomonas aeruginosa virulence factors by Ahmed, Syed et al.
1 
 
Natural Quorum Sensing Inhibitors 1 
Effectively Downregulate Gene Expression 2 
of Pseudomonas aeruginosa Virulence 3 
Factors 4 
 5 
 6 
Syed A K S Ahmeda, Michelle Ruddenb, Thomas J Smythc, James S 7 
Dooley*a, Roger Marchanta and Ibrahim M Banata 8 
 9 
aSchool of Biomedical Sciences, Ulster University, Coleraine, UK,  10 
bDepartment of Biology, University of York, Wentworth, York, YO10 5DD, UK  11 
cSchool of Science, Institute of Technology Sligo, Ireland 12 
*correspondence:  jsg.dooley@ulster.ac.uk 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
2 
 
ABSTRACT 22 
At present anti-virulence drugs are being considered as potential therapeutic alternatives and/or 23 
adjuvants to currently failing antibiotics. These drugs do not kill bacteria but inhibit virulence 24 
factors essential for establishing infection and pathogenesis through targeting non-essential 25 
metabolic pathways reducing the selective pressure to develop resistance. We investigated the 26 
effect of naturally isolated plant compounds on the repression of the quorum sensing (QS) 27 
system which is linked to virulence/pathogenicity in Pseudomonas aeruginosa. Our results show 28 
that trans-cinnamaldehyde (CA) and salicylic acid (SA) significantly inhibit expression of QS 29 
regulatory and virulence genes in P. aeruginosa PAO1 at sub-inhibitory levels without any 30 
bactericidal effect. CA effectively downregulated both the las and rhl QS systems with lasI and 31 
lasR levels inhibited by 13- and 7-fold respectively compared to 3- and 2-fold reductions with SA 32 
treatment, during the stationary growth phase. The QS inhibitors (QSI) also reduced the 33 
production of extracellular virulence factors with CA reducing protease, elastase and pyocyanin 34 
by 65%, 22% and 32%, respectively. The QSIs significantly reduced biofilm formation and 35 
concomitantly with repressed rhamnolipid gene expression, only trace amount of extracellular 36 
rhamnolipids were detected. The QSIs did not completely inhibit virulence factor expression and 37 
production but their administration significantly lowered the virulence phenotypes at both the 38 
transcriptional and extracellular level. This study shows the significant inhibitory effect of natural 39 
plant derived compounds on the repression of QS systems in P. aeruginosa.  40 
  41 
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INTRODUCTION 45 
A review commissioned by the UK government in 2014 (https://amr-review.org/) predicted that 46 
there will be more deaths in the world due to antimicrobial resistance (AMR) than cancer by the 47 
year 2050. Antibiotic usage creates an evolutionary stress response in the bacterial population 48 
that, over time leads to the emergence of resistant strains. Extensive use of antibiotics coupled 49 
with the diminished pipeline of new antibiotics has seen a rapid evolution of resistance that has 50 
culminated in the development of multi-drug resistant pathogens that are extremely difficult to 51 
treat.   52 
Pseudomonas aeruginosa, a Gram-negative opportunistic pathogen is prevalent in 53 
immunocompromised patients suffering from cystic fibrosis (CF) and human immunodeficiency 54 
virus (HIV). These bacteria are notorious biofilm producers. The biofilm provides a stratified 55 
environment with the core being more anoxic with low bacterial growth and metabolic rates. 56 
These metabolically inactive biofilm cells are resistant to the β-lactam antibiotics (Anwar and 57 
Costerton 1990, Werner et al 2004) ciprofloxacin, tetracycline and tobramycin (Brown et al 1988). 58 
The biofilm layer also acts as a diffusion barrier reducing the rate of antibiotic penetration, 59 
preventing sufficient accumulation of antibiotics and allowing time for expression of resistance 60 
genes (Jefferson et al 2005). In CF, P. aeruginosa forms biofilms and readily adapts to the lung 61 
environment eventually leading to prolonged inflammation and chronic lung infections that are 62 
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very difficult to treat using conventional antibiotic methods. In addition, the presence of 63 
inducible (MexXY) and constitutive (MexAB-OprM) efflux pumps and the poor permeability of 64 
the outer membrane also contribute to the reduced susceptibility of P. aeruginosa to a broad 65 
range of antibiotics (Aghazadeh et al 2014, Lopez-Causape et al 2017). Effective treatment of P. 66 
aeruginosa is therefore becoming increasingly challenging with the bacterium showing resistance 67 
to even the third and the fourth generations of carbapenems and cephalosporins (Luna et al 68 
2013, Patel et al 2014).   Therefore, it has become critical to find alternative therapies to 69 
successfully clear P. aeruginosa infections. 70 
P. aeruginosa produces a variety of virulence factors, in a coordinated system, that are reported 71 
to enable host colonisation and adaptation (Valderrey et al 2010, Gellatly and Hancock 2013, 72 
Sousa and Pereira 2014). These virulence factors include the production of biofilm, pyocyanin, 73 
elastase and rhamnolipid and are under the control of a cell density dependent signalling 74 
regulation known as quorum sensing (QS) (Stover et al 2000, Lee and Zhang 2014, Sousa and 75 
Pereira 2014) The canonical QS system in P. aeruginosa includes the las and the rhl systems both 76 
consisting of Lux-I type synthases (LasI and RhlI) which produce specific acyl homoserine lactone 77 
(AHL) molecules, N-(3-oxododecanoyl)-L-homoserine lactone (3-oxo-C12-HSL) and N-butanoyl-L-78 
homoserine lactone (C4-HSL). At sufficiently high bacterial concentrations, these AHL molecules 79 
then bind to the Lux-R type receptors (LasR and RhlR) to form transcriptional activation 80 
complexes which regulate the transcription of various genes involved with virulence of P. 81 
aeruginosa (Papenfort and Bassler 2016).  82 
Interfering with this QS system through application of QS inhibitors (QSI) is a novel therapeutic 83 
target that has shown to effectively reduce virulence in opportunistic pathogens. The disruption 84 
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of QS communication can be achieved through the enzymatic degradation of AHL molecules by 85 
lactonases, acylases and oxidoreductases or by using small structural molecules that inhibit the 86 
QS signal molecule from binding to its cognate regulatory protein (Morohoshi et al 2009, Kalia 87 
2013, Kisch et al 2014, Gupta et al 2015).   A synthetic derivative of a furanone, compound C30 88 
(C30F), has been shown to supress bacterial QS in mice lung models through interference with 89 
AHL production (Wu et al 2004) and through attenuation of QS regulated production of virulence 90 
factors (Henter et al 2003). In the recent past, a range of plant compounds have shown to be 91 
effective as anti-QS and anti-biofilm agents (Musthafa et al 2010, Jayelakshmi et al 2016, Ouyang 92 
et al 2016, Luo et al 2017). Kim et al. (2015), using an in silico approach, predicted that natural 93 
gingerol could bind to the QS regulator LasR protein. They then demonstrated, using standard 94 
assays, a decrease in production of several virulence factors and biofilm formation following 95 
exposure to gingerol, consistent with interference of the binding of the cognate signal molecule, 96 
3-oxo-C12-HSL, to LasR. Moreover, access to crystal structure of LasI (Gould et al 2004) and LasR 97 
(Bottomley et al 2007) along with the availability of computer-aided programs like structure 98 
based virtual screening (SB-VS) and molecular docking have been useful in identifying more 99 
compounds with potential anti-QS abilities. 100 
A SB-VS experiment unlocked six drugs with LasR structural similarity including salicylic acid (SA), 101 
nifuroxazide, and chlorzoxazone (Yang et al 2009). These compounds were able to significantly 102 
inhibit QS gene expression and phenotypes in P. aeruginosa.   In another study, molecular docking 103 
results showed that a plant compound, trans-cinnamaldehyde (CA), was able to interact with the 104 
LasI substrate binding sites by forming hydrophobic and π-π bonds with Phenylalanine- 27 and 105 
105, Tryptophan-33 and a hydrogen bond with Arginine-30 in the LasI synthase (Chang et al  106 
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2014). Since QS is related to several virulence mechanisms in P. aeruginosa, therefore the ability 107 
of compounds like SA and CA to interfere with the QS system can open the possibility of utilizing 108 
these as effective anti-QS agents for controlling the pathogenic phenotypes of P. aeruginosa.    109 
QS system allows bacteria to adapt to changing environmental conditions at the population level, 110 
with the adaptation mediated at the transcriptional level via regulated expression of the QS 111 
genes in response to metabolic and environmental stimuli (Wagner et al 2003, Scott and Hwa 112 
2011). Understanding the transcriptional expression of the QS genes is therefore essential for 113 
understanding the physiology of the cell under QS inhibitory conditions. The current information 114 
on the ability of CA and SA to reduce QS activity in P. aeruginosa is very limited and has been 115 
mostly acquired through crude estimations of virulence proteins or by using high throughput 116 
microarray analysis for identifying changes to gene expression (Prithiviraj et al 2005, Yang et al 117 
2009). Therefore, in this study we have used a very robust and MIQE (minimum information for 118 
publication of quantitative real-time PCR experiments) compliant reverse transcription-119 
quantitative PCR (RT-qPCR) assay, a gold standard for low-medium throughput quantitative 120 
expression analysis, to study the changes in transcriptomic profiles when P. aeruginosa is 121 
subjected to CA and SA treatments at sub-inhibitory concentrations. To correlate the effects of 122 
the gene expression on the phenotypic profiles following QSI treatment, the QS regulated 123 
virulence factors rhamnolipid, elastase, protease and pyocyanin were estimated.  124 
  125 
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Materials and Methods 126 
Bacterial strains and media 127 
 The fully sequenced and widely reported laboratory strain P. aeruginosa PAO1 (ATCC 15692) was 128 
used in the study. Overnight cultures were prepared from -80°C frozen culture stocks in a nutrient 129 
rich LB broth at 37°C under shaking conditions at 180 rpm. This culture was subsequently used 130 
to inoculate proteose-peptone-glucose-ammonium-salts (PPGAS) medium (Zhang and Miller 131 
1992). The bacteria were cultivated in PPGAS medium at 1/5th MIC levels of 2.27 mM CA and 3.62 132 
mM SA in either single or combination treatments. A positive control for QS was included using 133 
10 µM C30F (Skindersoe et al 2008). All experiments were carried out in biological triplicates. The 134 
experimental compounds were purchased from Sigma-Aldrich, UK unless otherwise stated.  135 
Minimum Inhibitory Concentration (MIC) determination  136 
The MIC of the test inhibitors against P. aeruginosa PAO1 was determined using the resazurin 137 
microtiter plate assay (Elshikh et al 2016) which used the redox indicator resazurin that changed 138 
colour from blue to pink in the presence of viable cells. The MIC was determined as the 139 
concentration at which there was no colour change following 4 hours incubation of the overnight 140 
cells with 0.015% resazurin.  141 
RNA isolation and purity assessment   142 
The cell pellets were collected from different growth phase cultures by spinning them at 13000 x 143 
g for 2-3 minutes at room temperature and the RNA extracted using JetGene RNA Purification Kit 144 
(Thermo Fisher Scientific). The cells were lysed with occasional vortexing in a buffer solution with 145 
1X TE buffer, 15 mg/ml lysozyme and 20 mg/ml proteinase K (Promega). The samples were then 146 
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transferred to a 2 ml Lysing Matrix A tube (MP Biomedicals) with β-mercaptoethanol containing 147 
RLT buffer (provided in the kit) for enhanced lysis. The contents in the lysing matrix tubes were 148 
then homogenized using the FastPrepTM FP 200 cell disrupter at speed 5.5 for 30 seconds. A 149 
double DNA-digestion treatment was done to ensure that the RNA was free of any genomic DNA 150 
(gDNA) contamination. The RNA isolated was quantified using the Nanodrop spectrophotometer 151 
with A260/A280 ratio of 1.8-2.1 being considered as pure. The integrity of the samples was checked 152 
by agarose gel electrophoresis for presence of two sharp distinct bands representing 23S and 16S 153 
rRNA. The integrity was further verified by analysing the samples in an Agilent 2100 Bioanalyzer 154 
where RNA Integrity Number (RIN) values greater than 8 were observed for all samples. The RIN 155 
is based on a numbering system from 1-10 with 1 being the most degraded and 10 being the 156 
most intact. The RNA samples were aliquoted and stored at -80°C.  157 
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) 158 
First strand cDNA was synthesized using SuperscriptTM Reverse Transcriptase II (Invitrogen). Each 159 
reaction mix contained DNase treated RNA (500 ng), 20-250 ng random primers (Promega), 10 160 
mM dNTPs and RNase free water to make to the reaction volume 15.6 μl. The reactions were 161 
heated at 65°C for 5 minutes before adding 5X strand buffer, 0.1 M DTT and RNase inhibitor 162 
(RNAse outTM Invitrogen) in final concentrations of 1X, 10 μM and 40 units respectively. The 163 
reactions were incubated at 25°C for 2 minutes before adding Superscript™ II Reverse 164 
Transcriptase (200 units final concentration) (Invitrogen). The RT reactions were carried out at a 165 
series of temperature starting with 25°C for 10 minutes, 42°C for 50 minutes and 70°C for 15 166 
minutes. The first strand cDNA synthesis was performed for all the biological triplicates from each 167 
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time point. A negative reaction without reverse transcriptase was included in every run. All cDNA 168 
samples were stored at -20°C prior to use.   169 
The cDNA synthesised was then used as a template for real time PCR amplification using the 170 
ROCHE LightCycler LC480 system with a SYBR-Green probe. Since PCR efficiency is highly 171 
dependent on primer specificity therefore a qPCR calibration curve was generated from each 172 
primer set using PAO1 gDNA. Only those primers which gave a calibration curve with a slope 173 
value between -3.1 to -3.6 that translated into amplification efficiencies of 90-110% were used 174 
for PCR quantification. The binding specificity of these primers were also validated post- 175 
amplification by generating a melt curve for each primer set with the presence of a single sharp 176 
peak eliminating the chances of any non-specific binding.  177 
The qPCR 10 µl reaction mix each contained 2X SYBR Green master mix (1X), forward and reverse 178 
primers (1 µM), cDNA template and molecular grade water. Negative controls in form of –RT (no 179 
reverse transcriptase) and no template control NTC (no DNA template added) were included to 180 
rule out any contamination during the preparation process. A positive control in the form of gDNA 181 
was also included. The cut-off values for residual gDNA amplification and NTC were set at greater 182 
than 35 and 40 cycles respectively. The cycling parameters were: initial denaturation at 95°C for 183 
5 minutes, 40-50 cycles of denaturation at 95°C for 10 seconds, annealing at 59°C for 10 seconds, 184 
extension at 72°C for 10 seconds.  185 
Reference gene validation 186 
A total of six candidate genes (gyrB, proC, cysG, rpoD, rpoB and 16S) were analysed under 187 
inhibitory conditions to assess for the most stable and reliable reference genes for this study. The 188 
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stability of the six candidate genes were validated under inhibitory conditions using three 189 
independent software packages geNorm (Vandesompele et al 2002), NormFinder (Andersen et 190 
al 2004) and BestKeeper (Pfaffl et al 2004). The geNorm algorithm measures the stability of the 191 
genes based on pairwise variation between one candidate gene and the other genes and was 192 
calculated using the online available tool RefFinder (Fu et al 2013).  The NormFinder model 193 
considers the intra- and inter- group variation to calculate the stability of the genes using a R-194 
based software excel package (MOMA, Aarhus University Hospital, Denmark). The BestKeeper is 195 
a free excel based tool that correlated the coefficient of the candidate gene with a BestKeeper 196 
Index to generate the most stable gene. The genes rpoD and proC were identified as most stable 197 
for use as reference genes in this study by the three algorithms.   198 
Relative Gene Expression Data Analysis 199 
System (LC480 software, version 2) generated analysis was performed on the real-time PCR data. 200 
The threshold values (Cq) values from each of the qPCR run was extracted from the LC480 system 201 
using the second derivative maximum method (Rasumssen 2001). Data analysis was performed 202 
by taking the arithmetic mean of the Cq values of the technical replicates and transferring it into 203 
log values to generate the relative quantities (RQ). The RQ values of the target genes were then 204 
divided by geometric mean of reference gene RQs (rpoD and proC) to give normalized relative 205 
quantity value (NRQ). The NRQ value was then divided by the experimental calibration which in 206 
the experiment was relative expression at early log (6-hour) and was set to 1. The output was the 207 
calibration normalized ratio (CNRQ) which was used in extrapolating information on the 208 
expression profile of the target genes. 209 
 210 
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Production of virulence factors 211 
An overnight PAO1 culture was used to inoculate PPGAS medium and incubated for 24 hours 212 
under continuous shaking at 37°C.  The supernatant was collected, and filter sterilized for use in 213 
the following assays: 214 
Protease: The amount of LasA protease produced by PAO1 following incubation with and without 215 
the inhibitors were estimated by adding 0.1 ml culture supernatant to a reaction mixture 216 
containing 0.8% azocasein in 500 µl of 50mM K2HPO4 (pH 7) and incubating at 25°C for 3 hours. 217 
The reaction was terminated by adding 0.5 ml of 1.5 M HCl and then keeping it on ice for 30 218 
minutes. The precipitated protein was removed by centrifugation (10000 x g for 10 minutes). 219 
NaOH (1N) was added to the supernatant in equal ratios and the concentration of acid soluble 220 
azopeptides measured spectrophotometrically at 440 nm.  221 
Elastase: The LasB elastase production was measured by adding 1 ml of the culture supernatant 222 
to a 2 ml reaction buffer (100 mM Tris-HCl, 1 mM CaCl2) containing the substrate elastin congo-223 
red and incubating for 3 hours at 37°C with shaking at 180 rpm. The reaction was terminated by 224 
adding 2 ml of 0.7 M sodium phosphate buffer (pH 6) and placing it on ice for 15 minutes. The 225 
absorbance of the supernatant was measured at 495 nm. 226 
Pyocyanin: The pyocyanin concentration was estimated by adding 7.5 ml filtered supernatant to 227 
4.5 ml of chloroform and vortexed until the colour changed to greenish blue. The samples were 228 
centrifuged (10000 x g for 10 minutes) and 3 ml of the resulting blue coloured liquid was 229 
transferred to a new tube containing 1.5 ml of 0.2 M HCl and shaken until the blue colour turned 230 
to pink. The pink layer was transferred to a cuvette and the absorbance measured at 520 nm. 231 
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The concentration was calculated in µg/ml by multiplying the absorbance by factor 17.072 (Essar 232 
et al 1990). 233 
Rhamnolipid extraction and purification 234 
The extraction of rhamnolipid was performed following the method of Smyth et al. (2010). The 235 
culture supernatant (50 ml) from PAO1 grown in PPGAS medium for 24 hours was acidified to pH 236 
2 and extracted with ethyl acetate three times. The organic solvent containing rhamnolipid was 237 
dried with anhydrous MgSO4 to remove residual water. Rhamnolipid was isolated from the ethyl 238 
acetate solvent in the form of yellow gummy residue after removing the organic solvent in a 239 
rotary evaporator. The rhamnolipid crude extract was then purified using solid phase extraction 240 
by running the samples through Strata SI-1 Silica (55 µM, 70A) Giga tubes (Phenomenex). After 241 
conditioning and removing the impurities from the column with chloroform, rhamnolipids were 242 
eluted using chloroform and methanol in ratios of 5:0.3, 5:0.5 and 1:1.   243 
Rhamnolipid separation and analysis by high performance liquid chromatography-mass 244 
spectrometry/mass spectrometry (HPLC-MS/MS)  245 
Analysis of the extracted rhamnolipid mixture was performed using a LCQTM quadrupole ion trap 246 
with a negative electrospray ionisation (ESI) interface connected to a Thermo HPLC Spectra 247 
system. A reverse phase C18 column with 5 µm particles was used to separate the rhamnolipids. 248 
The parameters included desolvation gas at 65 units and source temperature 250°C, 20 µl 249 
injection volume and 0.5 µl/min flow rate. Two mobile phases were used: HPLC grade water (A) 250 
and acetonitrile (B). The rhamnolipid congeners were resolved in a linear gradient mobile phase 251 
starting with 70%A:30%B to 30%A:70%B over 50 minutes and then back to 70%A:30%B for 55 252 
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minutes with a final hold of 5 minutes. Tandem mass spectrometry was carried out using ESI in a 253 
negative mode using collision induced dissociation (CID) at 35% peak within the MS range of 50-254 
800 m/z. 255 
Statistical analysis 256 
All statistical analysis was performed using the GraphPad prism v5. 257 
 258 
RESULTS 259 
Growth phase dependent expression of QS genes 260 
The effect of the QSIs on the QS system of the fully sequenced laboratory strain P. aeruginosa 261 
PAO1 (Stover et al 2000) was investigated by studying the transcriptional expression of the QS 262 
synthase and regulatory genes. Both lasR/lasI and rhlR/rhlI systems were expressed in a cell 263 
density dependent manner with expression levels increasing upon entering the stationary phases 264 
of growth (Fig. 1B). Maximum expression levels for all genes was detected in the mid-late 265 
stationary phase corresponding with highest cell density. In both las and rhl systems the 266 
autoinducer synthase genes (lasI and rhlI) were expressed earlier and at much higher relative 267 
concentrations in comparison to their cognate regulatory protein genes (lasR and rhlR). At high 268 
concentrations, LasR and RhlR bind to their cognate N-acyl homoserine autoinducer molecules; 269 
the bound complex is then a transcriptional regulator of several genes in P. aeruginosa.  270 
The QS system regulates productions of most of the P. aeruginosa virulence factors including the 271 
low molecular weight glycolipids rhamnolipids, that are under the direct regulation of the RhlR-272 
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RhlI system. The rhamnolipid biosynthetic genes display a differential expression profile where 273 
rhlA and rhlB are expressed earlier relative to rhlC, which is only maximally expressed after 274 
significant rhlAB expression (Fig. 2A-C). The products of rhlAB are responsible for the first step in 275 
rhamnolipid biosynthesis, which produce mono-rhamnolipids. Mono-rhamnolipids are in turn 276 
the substrate for the rhlC gene product to produce di-rhamnolipids. The differential sequential 277 
expression pattern observed for the rhamnosyltransferases from this data is suggestive of a co-278 
ordinated regulation based on the substrate availability.  279 
The other virulence-associated genes responsible for the production of the exoprotease LasA, 280 
and elastase LasB, were also transcriptionally expressed in a cell density dependent manner with 281 
maximum expression observed in mid-late stationary phase (Fig. 2D-E). The las regulated 282 
virulence genes lasA and lasB were shown to be significantly upregulated during the mid-late 283 
stationary phase with expression levels >300-fold relative to log phase levels (p<0.001).  284 
 285 
Quorum Sensing Inhibitors (QSIs) effectively downregulate the QS regulatory 286 
system  287 
Selectively interfering with QS systems is a novel strategy targeted at disarming virulent 288 
opportunistic pathogens such as P. aeruginosa. In Gram negative bacteria, QS is typically 289 
mediated by acyl-HSLs and rational analogues have been designed to specifically target these 290 
systems. Several phenolic compounds have been be shown to effectively disrupt QS systems in 291 
Gram negative bacteria (Hossain et al 2017). In this part of the study, we investigated the anti-292 
QS abilities of naturally isolated plant compounds CA, SA and a synthetic furanone compound, 293 
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C30F, reported to attenuate virulence in P. aeruginosa (Fig. 3A) (Hentzer et al 2003, Yang et al 294 
2009, Chang et al 2014). The minimum inhibitory concentration (MIC) of the test compounds CA 295 
and SA were determined as 11.35 mM and 18.1 mM respectively. The use of the QSIs at the sub-296 
inhibitory concentrations (1/5th MIC) did not affect the growth phenotype of P. aeruginosa PAO1 297 
(Fig. 3B).  CA treatment resulted in a longer lag phase but reached similar optical densities to 298 
untreated PAO1 within 6 hours of incubation. Since QS genes were significantly expressed in the 299 
stationary phase (Fig. 1B), we tested the effect of the QSIs on the expression of QS associated 300 
regulatory and virulence genes during mid to late stationary phase of growth, when the cell 301 
density was at its highest. 302 
CA at sub-inhibitory levels (2.27 mM) significantly (p<0.001) reduced the expression of the QS 303 
transcriptional regulatory genes lasR and rhlR (Fig. 3C). CA caused a 7-fold reduction (p<0.001) in 304 
lasR gene expression while the difference between the untreated and treated cells was even 305 
higher in the LasR-controlled rhlR expression with a reduction of 19-fold being observed. CA also 306 
effected a significant (p<0.001) reduction in the AHL synthase gene expressions during the 307 
stationary phase of growth. The downregulation in the rhlI synthase gene following treatment 308 
was 6-fold while in lasI synthase it was 13-fold during the late stationary phase. 309 
The second inhibitor tested was the plant hormonal compound SA at sub-inhibitory 310 
concentration of 3.62 mM. This also caused inhibition in QS gene expressions but unlike CA the 311 
overall reductions were lower (Fig. 3C). The compound seemed to have a greater inhibitory effect 312 
on the las QS circuit unlike CA which effectively repressed both las and rhl QS synthase and 313 
regulatory genes. The down-regulation in QS transcriptional regulatory genes lasR and rhlR due 314 
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to SA treatment was 2-fold and 4-fold respectively. The transcript levels of the lasI synthase gene 315 
was three times lower following SA treatment, while there was no significant reduction in 316 
expression of the rhlI synthase gene in the stationary phase. The behaviour of the lasR and rhlR 317 
regulatory genes determine the expression of virulence-related genes associated with the QS 318 
mechanisms in P. aeruginosa, therefore these results suggest that SA would not produce a very 319 
high down-regulation in QS regulated virulence gene expressions in comparison to CA. 320 
Although CA and SA when used alone did show reduction in most QS gene transcripts but when 321 
used in combination (PAO1+CA+SA) the results were inconclusive (Fig. 3C). The combination 322 
treatment influenced the lasI synthase expression where it reduced the transcript level by 5-fold.  323 
A similar reduction (3-fold) was also observed in the transcriptional regulator rhlR expression. 324 
However, the combination treatment did not exert any significant effect on the expression levels 325 
of the lasR and rhlI genes.  These results suggest that the inhibitory effects of CA and SA on the 326 
QS gene transcriptions were compromised when used in combination.  327 
The positive control C30F produced an expected inhibitory effect on the rhl circuit of P. 328 
aeruginosa during the mid-late stationary phase when used at a concentration of 10 µM (Fig. 3C). 329 
The rhlR transcript level was reduced 5-fold while the synthase gene rhlI was repressed by 2-fold. 330 
The compound did not produce any significant inhibition on the transcription levels of the lasRI 331 
genes. 332 
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Trans-cinnamaldehyde significantly reduces expression of QS regulated 333 
virulence factors 334 
After investigating the effect of the experimental inhibitors on the QS master genes- lasRI and 335 
rhlRI, the study focused on investigating the inhibitory effects on the las and rhl QS regulated set 336 
of virulence genes.  The target genes selected were las controlled lasA protease and lasB elastase 337 
and rhl regulated genes rhlA, rhlB and rhlC associated with rhamnolipid production (Fig. 4A). The 338 
target gene expression was normalized using validated reference genes, rpoD and proC, across 339 
all culture conditions. 340 
The significant inhibition in lasRI expressions in P. aeruginosa PAO1 when subjected to CA as seen 341 
before, affected the mRNA transcript levels of the lasA and lasB genes (Fig. 4B). The relative 342 
expression data showed a 19-fold (p<0.001) reduction in lasA gene expression while lasB showed 343 
a 7-fold (p<0.001) reduction when compared to the untreated cells during the mid-late stationary 344 
growth phase. The compound was also effective in highly repressing the expression of the 345 
rhamnolipid synthesis rhlABC genes during stationary phase (Fig. 4B).  The reduction in transcript 346 
level of rhlA was observed as greater than 100-fold (p<0.001). A significantly high down-347 
regulation was also observed in rhlB (p<0.05) expression while a 2-fold reduction (p<0.05) was 348 
observed in rhlC expression.  349 
The ability of SA to repress the las QS genes lasI and lasR (Fig. 3C) consequently influenced the 350 
virulence gene expressions of lasA and lasB. The transcript levels of lasA and lasB were reduced 351 
by 4-fold (p<0.001) and 2-fold (p<0.01) respectively when treated with 3.62 mM SA (Fig. 4C). It 352 
can be hypothesised that the inability of SA to produce an inhibitory effect on rhlI synthase gene 353 
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expression (Fig. 3C) meant there were enough signal molecules to drive the expression of the 354 
rhlABC genes. Although a 3-fold (p<0.001) reduction was observed in rhlA gene expression, partly 355 
due to the reduced expression of the rhlR regulatory gene, the overall inhibitory effect seemed 356 
small as insignificant reductions in rhlB and rhlC gene expressions were observed with SA at the 357 
concentration tested in this experiment (Fig. 4C). 358 
The down-regulation in the lasI synthase gene when treated with both 2.27 mM CA and 3.62 mM 359 
SA did not correlate in a mRNA reduction of the las regulated virulence genes lasA and lasB (Fig. 360 
4D).  However, the ability of the combination treatment to repress the QS regulatory rhlR gene 361 
caused a significant down regulation (p<0.001) in the rhlAB genes. The combination treatment 362 
exerted a 4-fold decrease in the rhlA gene and 6-fold decrease in the rhlB gene expressions 363 
compared to the untreated samples. Interestingly, a minor up regulation of 2-fold was observed 364 
in the rhlC gene.  365 
The inability of C30F to reduce las regulated QS regulatory and synthase gene expressions was 366 
only validated in the target gene expression analysis with no reduction being observed in las 367 
controlled virulence lasA and lasB expressions (Fig. 4E). But C30F’s ability to reduce rhlRI had a 368 
consequential effect on the expression of rhlAB genes with reduction of 2-fold and 3-fold in rhlA 369 
and rhlB gene expressions respectively at late-mid stationary phases. 370 
 371 
  372 
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QSIs reduce production of extracellular virulence factors at sub-MIC 373 
concentrations 374 
Biofilm formation: The ability of P. aeruginosa PAO1 to form biofilm was assessed using a widely 375 
employed in vitro model outlined by O’Toole (2011) with slight modifications. The biofilm growth 376 
was visualized as a ring of biomass stained with crystal violet at the air-liquid interface.  The 377 
biofilm formation was evaluated both in the presence and absence of inhibitory compounds, by 378 
measuring the absorbance of crystal-violet-stained-adherent-cells solubilized in ethyl acetate at 379 
570 nm from stationary phase cultures (24-hour) (Fig. 5A). There were significant (p<0.001) 380 
reductions in treated samples compared to the untreated PAO1. In comparison to CA, SA was 381 
more effective in reducing the formation of biofilm in the microtiter wells with an absorbance 382 
reduction of 54% compared to the untreated cells. CA was also effective, to a lesser degree, with 383 
reductions of 26%. The combined use of CA and SA was the most effective of the treatment 384 
methods with a reduction of 62%. The positive control C30F in comparison was the least effective 385 
(24%) in reducing biofilm formation. 386 
LasA protease: There were significant reductions in LasA protease activity in the QSI treated cells 387 
as estimated from absorbance reading resulting from azo dyes released into the medium due to 388 
proteolytic cleavage of the substrate azocasein. In the presence of SA, the OD440 dropped from 389 
0.3 to 0.1 to account for a 31% reduction (p<0.05) in absorbance reading while CA treatment 390 
gave an even higher reduction of 65% (p<0.01). The combination QSIs (CA+SA) treatment 391 
produced the highest reduction in protease production with a reduction of 80% (p<0.001) 392 
absorbance being observed when compared to the untreated PAO1 (Fig. 5B). 393 
20 
 
LasB elastase: The elastase production was estimated through absorbance measurement of 394 
congo red following cleavage of elastin-congo red substrate by the enzyme elastase produced by 395 
P. aeruginosa. In presence of inhibitors CA and SA, the OD495 decreased from 0.08 to 0.06 and 396 
0.05 respectively giving subsequent reduction percentages of 22% (p<0.01) and 28% (p<0.05) 397 
(Fig. 5C). The combination treatment was again the most effective in reducing absorbance with 398 
reduction of 46%. However, like the protease assay, C30F was the least effective, confirming 399 
earlier results of its reduced inhibitory effects on lasA and lasB gene expressions. 400 
Pyocyanin: Pyocyanin production is regulated by the rhl QS via PQS, hence the measurement of 401 
pyocyanin inhibition is also a good indicator of the effectiveness of the tested compounds as QS 402 
inhibitors in P. aeruginosa. The pyocyanin concentration decreased from 3.1 µg/ml to 2.1 µg/ml 403 
and 0.922 µg/ml in the presence of CA and SA respectively. When used together, the inhibitors 404 
decreased the yield by 64% (1.1 µg/ml) (Fig. 5D).  405 
Rhamnolipid estimation: The administration of the QS inhibitors caused a reduction in the yield 406 
of rhamnolipid with CA and SA both producing a drop in crude weight from 1.72 g/l to 0.7 g/l 407 
(approximately) (Fig. 6A). Rhamnolipids are produced as congeners containing one to two 408 
rhamnose sugar moieties giving the compounds their distinctive properties (Chen et al 2010, 409 
Chen et al 2013). The structural composition of rhamnolipid produced in the presence of the QSIs 410 
was studied by analysing the purified crude sample using HPLC-MS/MS method. The inhibitor 411 
treatment when used alone did not affect the composition of the rhamnolipid with the congener 412 
profile resembling the untreated PAO1 sample (Fig. 6C). But in the combination treatment 413 
(PAO1+CA+SA) only 2 rhamnolipid congeners were detected by the HPLC-MS/MS method (Fig. 414 
6D) compared to 6 in the untreated sample. This combination treatment also effected the 415 
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maximum reduction in the relative amount of rhamnolipid obtained from a 50-ml culture 416 
supernatant. The two predominant congeners identified in all the samples were Rha-Rha-C10-C10 417 
(m/z 649) and Rha-Rha-C10-C12 (m/z 677). The mono-rhamnolipid detected in greatest abundance 418 
was Rha-C10-C10. When the MS data for the two common di-rhamnolipid congeners were 419 
compared to untreated sample, the combination treatment and CA treatment showed marked 420 
differences (Fig. 6B). SA treatment did not show any noticeable difference in relative 421 
quantification of the congeners although it resulted in a decrease in crude weight.  422 
 423 
 424 
DISCUSSION  425 
Trans-cinnamaldehyde is more effective than salicylic acid in reducing expression 426 
of QS genes 427 
This study is consistent with previous research showing that natural QSIs significantly modulate 428 
transcriptional expression of QS regulatory and virulence-associated genes during stationary 429 
phase in P. aeruginosa PAO1. CA effectively inhibited the expression of both las and rhl QS 430 
systems. Both the regulatory proteins (LasR and RhlR) and the AHL synthases (LasI and RhlI) were 431 
significantly repressed with CA.  Downregulation of both these QS systems correlated with 432 
repression of their virulence associated genes.  The exact mechanism of action in unknown for 433 
these compounds. Several natural and synthetic antagonists have been described for LasR 434 
however the relative instability of LasR::antagonist complexes has limited biochemical 435 
characterision in vitro.  Recently (O’Reilly et al 2018) used potent agonists rather than known 436 
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antagonists to stabilise LasR in vitro. They were able to develop a focused library of agonists 437 
based on previous tri-phenyl ligands, resulting in several new LasR::agonist complexes available 438 
in/from the PDB. From these structures O’Reilly et al.(2018) determined an important 439 
functional role for a flexible loop in the ligand binding domain (LBD), previously unknown, which 440 
upon ligand binding  promotes specific conformational changes that seals the ligand binding 441 
pocket from solvent and directs the DNA binding domain (DBD) to form a transcriptional 442 
activation complex.  This suggest a plausible mechanism by which agonists stabilise and 443 
antagonists destabilise LasR.  These structures provide essential information for the fundamental 444 
understanding of how LuxR type receptors bind to their cognate autoinducers.  445 
We hypothesise that CA and SA act as QS antagonists. Previously, molecular docking studies have 446 
suggested CA to interact with the LasI protein (Chang et al 2014). LasI synthase produces 3-oxo-447 
C12-HSL which is the ligand for LasR. RhlI is 47% homologous with LasI (, Chang et al 2014. Gokalsin 448 
et al 2017) and a similar mechanism of action is interpreted in AHL production. In general, LuxI 449 
synthases catalyzes the transfer of an acyl group bound to acyl carrier protein (ACP) from fatty 450 
acid bio- synthesis to S-adenosyl–L-methionine (SAM) (Churchill and Chen 2011) which then 451 
undergoes lactonization to form the N-acyl–homoserine lactone.  CA is predicated to bind in the 452 
SAM binding pocket of LasI, thus preventing SAM binding and subsequent 3-oxo-C12-HSL 453 
synthesis, In the absence of AHL, LasR will not dimerize and therefore cannot bind to DNA. These 454 
interactions could modulate the QS autoinducer levels. The LasI::3-oxo-C12-HSL complex 455 
regulates the expression of many downstream genes including lasI and rhlI. Since we showed CA 456 
reduces lasI expression and previously CA has shown to reduce signal molecule concentration 457 
(Chang et al 2014), we suggest that the intracellular concentration of autoinducer signal 458 
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molecules was not sufficient to trigger the activation of genes involved with rhamnolipid and 459 
protease synthesis as shown in this study.  460 
To date there is no crystal structure for RhlR, its inherent instability in vitro has proven intractable 461 
to crystallisation and biochemical characterisation. Based on similarity, mechanistic 462 
interpretations of LasR with AHL ligands and inhibitors are expected to extend to RhlR. However, 463 
RhlR remains a viable QS target for developing targeted inhibitors, lasR mutants are frequently 464 
isolated from cystic fibrosis patients suggesting the redundancy of LasR as a master regulatory in 465 
chronic CF infections (Feltner et al 2016).   466 
The reductions in lasRI and rhlRI expressions from CA treatments were correlated by assessing 467 
the activity of las regulated elastase and protease and rhl regulated pyocyanin and rhamnolipid 468 
productions. CA at sub-inhibitory concentrations caused a significant decrease in elastase (22%) 469 
and protease (65%) activities. Pyocyanin, which is a good indicator of rhlI inhibition (Chang et al 470 
2014), showed a decrease of 32% with CA. These reductions were comparable to other findings 471 
with cinnamaldehyde as QSI in the literature (Brackman et al 2008, Brackman 2011). Although 472 
CA was not able to abolish rhamnolipid production, the treatment caused a decrease in 473 
rhamnolipid yield with the two main di-rhamnolipid congeners Rha-Rha-C10-C10 and Rha-Rha-C10-474 
C12 levels reduced by 59% and 34% respectively compared to that of untreated cells. The 475 
inhibition at post-translational levels of these virulence factors complemented the RT-qPCR data 476 
from this study where we observed significant reductions in lasA, lasB, rhlA, rhlB and rhlC 477 
expressions following CA treatment.  478 
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SA unlike CA did not produce the same level of inhibition on the transcriptional profiles of the 479 
lasRI and rhlRII genes with 2-4-fold reduction in mRNA levels being observed in the treated 480 
samples compared to untreated controls. The binding affinity of SA to the LasR protein (Yang et 481 
al 2009) possibly promoted conformational changes in the LasR-(3-oxo-C12-HSL) complex thereby 482 
causing a reduced expression of downstream genes. Due to the QS hierarchical arrangement, 483 
rhlR expression can be regulated by lasR, hence the highest inhibition in QS regulatory expression 484 
with SA was seen in rhlR. This was in agreement with a previously reported study where SA was 485 
shown to reduce rhlR expression in P. aeruginosa (Yang et al 2009). The decreased expression in 486 
las QS genes consequently repressed lasA and lasB levels supporting the findings of Prithiviraj et 487 
al. (2005) using SA. Since SA did not lead to an inhibitory effect on the overall rhl regulon, 488 
significant downregulation was not observed in the rhlB and rhlC genes. El-Mowafy et al. (2014) 489 
reported SA rich aspirin could cause significant downregulation in the lasRI and rhlRI expressions. 490 
The findings however do not fully agree with the results from this study. The study with aspirin 491 
(El-Mowafy et al 2014) used only one reference gene, rpoD, for data normalization along with a 492 
higher concentration of the inhibitor thereby giving slightly different results. Although SA did not 493 
show a profound effect at the transcriptional level, it seemed to be effective at the translational 494 
level. This can be hypothesized from this study considering higher reductions in virulence 495 
proteins elastase and protease were observed in the semi-quantitative assays following SA 496 
treatment. Reduction of these proteases when P. aeruginosa were supplemented with SA had 497 
been previously reported in a couple of studies with inhibition ranging between 40-80% 498 
(Prithiviraj et al 2005, El-Mowafy et al 2014). The choice of semi-quantitative assay and the 499 
selection of growth medium were perhaps responsible for the large inhibitory range being 500 
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observed within the results published in the literature (Duan and Surette 2007). The choice of 501 
media is very important as the production of secondary metabolites can be influenced by growth 502 
limiting factors present in the medium. However, SA had a negligible effect on the rhl controlled 503 
rhamnolipid production with HPLC results being similar to the untreated sample. This 504 
complemented the qPCR findings where minimal reduction was seen in the rhamnolipid 505 
biosynthesis gene expressions. Moreover, the unavailability of the RhlR crystal structure makes 506 
it difficult to predict the possible interaction sites for these inhibitors.  507 
The combination treatment of CA and SA does not show significant inhibitory 508 
effect on QS gene expressions 509 
Having ascertained the potential of CA and SA to repress QS regulated gene expressions and 510 
virulence factor production when used separately, the effect of combination treatment was 511 
investigated. Even though CA and SA have different QS targets, in the form of LasI and LasR 512 
respectively, expression profiles suggested that the combination treatment was not very 513 
effective at the transcriptional level. Noticeable downregulation was observed in rhlR which 514 
subsequently affected the expression of the rhamnolipid genes, further supporting the view that 515 
inhibitors targeting transcriptional regulators can be a potential drug target for reducing bacterial 516 
virulence. At post-translational level, the combination treatment was successful in reducing the 517 
rhl regulated production of pyocyanin and rhamnolipid. The HPLC-MS/MS analysis showed 518 
negligible presence of rhamnolipids strengthening the idea that the effect of the combination 519 
treatment was strongly at the translational level. A computational model study of LuxI/LuxR QS 520 
suggested that LuxR competitive inhibitor, unlike LuxR non-competitive inhibitor, can display 521 
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antagonistic effects when used in combination with a LuxI inhibitor (Anand et al  2013). 522 
Therefore, if an analogy is drawn with SA targeting LasR through competitive inhibition then 523 
some of the inhibitory potential of LuxI-type inhibitor CA can be attenuated. However, the 524 
mechanism by which this could happen is not known and was beyond the scope of current work. 525 
A better understanding on how the inhibitors bind to the target proteins will help to elucidate 526 
the lower inhibitory effects observed at expression levels with the combination treatment 527 
especially when we consider that significant downregulation was observed with CA alone.  528 
With antibiotics fast losing their efficacy, alternative strategies are imperative. The sole use of QS 529 
inhibitors is unlikely to completely eradicate the bacterial infection and there would be legitimate 530 
concerns around potential toxicity of high concentrations of cinnamaldehyde where maximum 531 
permissible levels in foodstuffs have already been determined (Shreaz et al 2016). However, since 532 
the inhibitors reduce the virulence phenotypes and weaken the bacterial biofilms, this would 533 
allow the host innate immunity and externally administered antimicrobial compounds to function 534 
more effectively. Synergistic enhancement of antibiotics by administration of sub-inhibitory 535 
quorum quenching compounds is a potentially exciting future development but little is known 536 
about such effects at the molecular level. Our system provides a suitable model system for future 537 
studies aimed at elucidating these mechanisms and should contribute to extending the useable 538 
life span of current drugs.   539 
 540 
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Figure 1 Las and rhl QS regulatory genes in P. aeruginosa PAO1 are differentially 711 
expressed in a cell density dependent manner. 712 
(A) Growth of P. aeruginosa in phosphate limited media (PPGAS).  (B) Transcriptional expression 713 
of QS regulatory genes lasR, lasI, rhlR and rhlI. Expression levels were quantified by RT-qPCR, 714 
relative mRNA levels for target genes were normalised to the geometric mean of two reference 715 
genes (rpoD and proC) and values plotted are the mean calibrator normalised ratios to log phase 716 
(6h). Vertical bars represent S.D± (n=3). Data was analysed using one-way ANOVA followed by 717 
Dunnett’s Multiple Comparison test (**p<0.01, ***p<0.001).  718 
 719 
Figure 2 QS regulated virulence associated genes are highly expressed in stationary phase 720 
in P. aeruginosa PAO1. 721 
Relative transcript levels of virulence associated rhamnolipid biosynthetic genes (A) rhlA, (B) rhlB 722 
(C) rhlC and exoprotease (D) lasA and elastase (E) lasB.  Relative mRNA levels for target genes 723 
were normalised to the geometric mean of two reference genes (rpoD and proC) and values 724 
plotted are the mean calibrator normalised ratios to log phase (6h). Vertical bars represent S.D± 725 
(n=3). Data was analysed using one-way ANOVA followed by Dunnett’s Multiple Comparison test 726 
(*p<0.05, **p<0.01, ***p<0.001). 727 
  728 
34 
 
Figure 3  Quorum Sensing Inhibitors (QSIs) significantly reduce expression of las and rhl 729 
QS systems in P. aeruginosa. 730 
(A) Molecular structure of the natural QSIs used in this study, Salicylic acid (SA), trans 731 
cinnamaldehyde (CA) and positive control furanone C30 (C30F). (B) Growth of P. aeruginosa with 732 
QSIs at sub-MIC concentrations (SA: 3.62 mM, CA: 2.27 mM and C30F: 10 µM). (C) Relative 733 
expression of QS regulatory genes lasR, lasI, rhlR and rhlI with combinations of QSI treatments. 734 
Relative mRNA levels for target genes were normalised to the geometric mean of two reference 735 
genes (rpoD and proC). Vertical bars represent S.D± (n=3). Data was analysed using two-way 736 
ANOVA followed by Bonferroni post-tests (**p<0.01, ***p<0.001). 737 
 738 
Figure 4  Trans-cinnamaldehyde (CA) significantly reduces gene expression of virulence 739 
associated genes in P. aeruginosa PAO1.  740 
(A) The schematic representation of the genetic location of las and rhl QS systems in P. 741 
aeruginosa.  Effect of QSIs at the following concentrations of: (B) 2.27 mM CA (C) 3.62 mM SA (D) 742 
2.27 mM CA + 3.62 mM SA and (E) 10 µM C30F on the transcriptional expression of virulence 743 
associated genes lasA, lasB, rhlA, rhlB and rhlC in P. aeruginosa PAO1. Gene expression was 744 
quantified at 24h for both treated and untreated cells, relative mRNA levels for target genes were 745 
normalised to the geometric mean of two reference genes (rpoD and proC). Vertical bars 746 
represent S.D± (n=3). Data was analysed using two-way ANOVA followed by Bonferroni post-tests 747 
(*p<0.05, ** p<0.01, ***p<0.001). 748 
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Figure 5  QSIs quantitatively reduce production of extracellular virulence factors in P. 749 
aeruginosa.PAO1 750 
QS regulated phenotypes (A) biofilm formation and extracellular factors (B) protease (C) elastase, 751 
and (D) pyocyanin were significantly disrupted by QSIs. The percentage reductions mentioned 752 
were calculated against the untreated PAO1.  Error bars represent S.D± (n=3). Data was analysed 753 
using one-way ANOVA followed by Dunnett’s Multiple Comparison test (*p<0.05, **p<0.01, 754 
***p<0.001).  755 
 756 
Figure 6  QSIs significantly reduce rhl regulated rhamnolipid production P. aeruginosa. 757 
(A) The QSIs reduces the rhamnolipid crude yield significantly compared to the untreated PAO1 758 
cells. (B) % reduction in the two main RL congeners Rha-C10-C10 and Rha-Rha-C10-C10 relative to 759 
untreated P. aeruginosa PAO1. RL congeners were studied by HPLC-MS/MS. The HPLC 760 
chromatograms of (C) untreated P. aeruginosa PAO1 and (D) P. aeruginosa PAO1 treated with 761 
trans-cinnamaldehyde (CA) and salicylic acid (SA).  762 
 763 
